Xenon Pharmaceuticals Inc.
Substituted benzamides useful as sodium channel blockers
Last updated:
Abstract:
The invention provides compounds having the general formula (I): and pharmaceutically acceptable salts thereof, wherein the variables R.sup.A, R.sup.AA, n, ring A, X.sup.2, L, m, R.sup.1, R.sup.2, R.sup.3, R.sup.4, R.sup.5, and R.sup.N have the meaning as described herein, and compositions containing such compounds and methods for using such compounds and compositions. ##STR00001##
Status:
Grant
Type:
Utility
Filling date:
22 Nov 2016
Issue date:
26 Jan 2021